8th Annual
Global Medical Affairs
Summit
16 – 17 September 2026 | Berlin
Speakers
SEE THE SPEAKERS & CASE STUDIES
CASE STUDY
Reimagining Global Medical Information: From Service to Strategic Impact
Global Medical Information is evolving from a reactive service to a strategic driver within Medical Affairs. This session explores how GMI can generate actionable insights, leverage digital and AI capabilities, and enable better decision-making across the organisation. We will highlight key enablers, organisational shifts, and practical approaches to unlock greater impact, positioning GMI as a critical contributor to scientific leadership and patient outcomes.
- 01From reactive answers to proactive insights
- 02Data, digital, and Al as key enablers
- 03Better, faster Medical Affairs decisions
- 04Integrated omnichannel engagement
- 05Impact over volume metrics
Traditionally, Regulatory Affairs relied on unstructured data that are maintained in documents. This is slowly but steadily changing as regulators demand the submission of structured data in addition to documents (e.g., XEVMPD and IDMP requirements). Being able to manage structured substance and product data will, in the future, be a prerequisite to further speed up the regulatory submission process and be a distinguishing factor in increasing development to market speed. Ontologies are a scalable approach to manage large quantities of regulatory data, break up data siloes and connect data even beyond regulatory requirements. We will dive into the world of ontologies to showcase how Regulatory Affairs can profit from this technological innovation.
CASE STUDY
Designing With, Not For: The Future of Patient Partnership in Medical Affairs
This session challenges Medical Affairs professionals to turn patient centricity from a guiding principle into a measurable practice — across how activities are designed, evidence is built, and outcomes are evaluated.
- 01Learn from experience: Explore what authentic co-creation with patients and advocacy groups truly requires — drawing on real-world examples
- 02Challenge the status quo: Examine where patient voice is genuinely shaping evidence and communications, and where critical gaps remain
- 03Build for impact: Begin establishing a practical framework to identify, address, and measure what real patient impact looks like in your organisation
Payit is UAE’s first fully featured digital wallet. This presentation narrates the story of how a digital wallet transformed financial transactions for families and communities in the region into joyful moments by thoughtfully curating experiences centred around customers’ spending, sending, and borrowing moments, enabled by the comfort and convenience of digital. This led to the wider acceptance of Payit and an upsurge in usage and profitable revenues.
CASE STUDY
How Can We Achieve True Patient Collaboration in Medical Affairs?
What do we mean by true patient collaboration? Why are medical affairs best placed to collaborate with patients? What are some of the challenges in true patient collaboration? What are the advantages of true patient collaboration? What could be some of the ways we can achieve this in the industry?
- 01Definition of patient engagement
- 02Why medical affairs
- 03Some challenges in true collaboration
- 04Some benefits of true patient collaboration
- 05What are we doing now and what can we do more of
This presentation will provide an in-depth analysis of the financial industry’s transformation, from its traditional banking roots to the rise of fintech and the disruptive influence of Web3 technologies. By examining the historical context, key innovations, and future implications, we will gain a comprehensive understanding of how the financial landscape has been reshaped and what the future holds for the industry. Join me to understand finance’s past, present, and future in a rapidly changing digital world.
CASE STUDY
Medical Affairs Strategy and Implementation – Adapt with Commercialisation Model
We will explore effective strategies for attracting and retaining top talent within the medical affairs sector. We will delve into the importance of creating a compelling employer brand and fostering a culture of continuous learning and development. Additionally, we will discuss the role of leadership in driving employee engagement, as well as insights and practical tools to enhance talent management practices and build a resilient, high-performing medical affairs team.
- 01Adapting Medical Affairs strategies to different commercialisation models
- 02Building and managing effective Medical Affairs capabilities within partner and distributor networks
- 03Supporting successful launches and lifecycle management (LCM) of specialty and rare disease products
- 04Ensuring scientific consistency, compliance, and stakeholder engagement across multiple markets
- 05Lessons learned and best practices from global and regional implementation
In today’s rapidly evolving digital landscape, the banking sector faces increasingly sophisticated cyber threats. As banks continue to innovate and expand their digital services, ensuring robust cybersecurity measures is more critical than ever. This presentation, titled “Evolving Cybersecurity in the Banking Sector: Strategies for Adapting to Emerging Threats,” will explore the latest trends in cyber threats, discuss effective strategies for mitigating risks, and highlight best practices for maintaining security in an ever-changing environment. Join us as we delve into the challenges and solutions that are shaping the future of cybersecurity in banking.
CASE STUDY
Which KPIs Actually Prove Impact to Leadership?
Despite a decade long discussion, no true standards to measure the value and impact of Medical Affairs beyond measuring quantity (e.g. number of MSL interactions, number of publications) are established. Capturing clinical adoption and closing of care gaps as ultimate goals remains elusive for most companies. This presentation will focus on a framework with the pillars from activity metrics to changes in knowledge/beliefs/ behaviour to impact on patient outputs and outcomes including examples and interactive discussions.
Global collaboration between companies across the supply chain provides tremendous value to products brought to market, patient safety and understanding of evolving requirements. It allows for an increase in product quality, supports smooth registration processes and thus secures the time it takes to introduce the product to the market. A similar situation may also occur with cooperation with regulatory bodies; the exchange of knowledge and experience can only have a positive impact on product safety. As a person who has been supporting cooperation in the area of regulatory affairs for many years, I would like to show, based on examples, how many benefits it can bring.
- 01KPI framework
- 02Patient impact measurement
- 03Case discussions
- 04Implementation and pitfalls
CASE STUDY
Reimagining Global Medical Information: From Service to Strategic Impact
Global Medical Information is evolving from a reactive service to a strategic driver within Medical Affairs. This session explores how GMI can generate actionable insights, leverage digital and AI capabilities, and enable better decision-making across the organisation. We will highlight key enablers, organisational shifts, and practical approaches to unlock greater impact, positioning GMI as a critical contributor to scientific leadership and patient outcomes.
- 01From reactive answers to proactive insights
- 02Data, digital, and Al as key enablers
- 03Better, faster Medical Affairs decisions
- 04Integrated omnichannel engagement
- 05Impact over volume metrics
Traditionally, Regulatory Affairs relied on unstructured data that are maintained in documents. This is slowly but steadily changing as regulators demand the submission of structured data in addition to documents (e.g., XEVMPD and IDMP requirements). Being able to manage structured substance and product data will, in the future, be a prerequisite to further speed up the regulatory submission process and be a distinguishing factor in increasing development to market speed. Ontologies are a scalable approach to manage large quantities of regulatory data, break up data siloes and connect data even beyond regulatory requirements. We will dive into the world of ontologies to showcase how Regulatory Affairs can profit from this technological innovation.
CASE STUDY
Designing With, Not For: The Future of Patient Partnership in Medical Affairs
This session challenges Medical Affairs professionals to turn patient centricity from a guiding principle into a measurable practice — across how activities are designed, evidence is built, and outcomes are evaluated.
- 01Learn from experience: Explore what authentic co-creation with patients and advocacy groups truly requires — drawing on real-world examples
- 02Challenge the status quo: Examine where patient voice is genuinely shaping evidence and communications, and where critical gaps remain
- 03Build for impact: Begin establishing a practical framework to identify, address, and measure what real patient impact looks like in your organisation
Payit is UAE’s first fully featured digital wallet. This presentation narrates the story of how a digital wallet transformed financial transactions for families and communities in the region into joyful moments by thoughtfully curating experiences centred around customers’ spending, sending, and borrowing moments, enabled by the comfort and convenience of digital. This led to the wider acceptance of Payit and an upsurge in usage and profitable revenues.
CASE STUDY
How Can We Achieve True Patient Collaboration in Medical Affairs?
What do we mean by true patient collaboration? Why are medical affairs best placed to collaborate with patients? What are some of the challenges in true patient collaboration? What are the advantages of true patient collaboration? What could be some of the ways we can achieve this in the industry?
- 01Definition of patient engagement
- 02Why medical affairs
- 03Some challenges in true collaboration
- 04Some benefits of true patient collaboration
- 05What are we doing now and what can we do more of
This presentation will provide an in-depth analysis of the financial industry’s transformation, from its traditional banking roots to the rise of fintech and the disruptive influence of Web3 technologies. By examining the historical context, key innovations, and future implications, we will gain a comprehensive understanding of how the financial landscape has been reshaped and what the future holds for the industry. Join me to understand finance’s past, present, and future in a rapidly changing digital world.
CASE STUDY
Medical Affairs Strategy and Implementation – Adapt with Commercialisation Model
We will explore effective strategies for attracting and retaining top talent within the medical affairs sector. We will delve into the importance of creating a compelling employer brand and fostering a culture of continuous learning and development. Additionally, we will discuss the role of leadership in driving employee engagement, as well as insights and practical tools to enhance talent management practices and build a resilient, high-performing medical affairs team.
- 01Adapting Medical Affairs strategies to different commercialisation models
- 02Building and managing effective Medical Affairs capabilities within partner and distributor networks
- 03Supporting successful launches and lifecycle management (LCM) of specialty and rare disease products
- 04Ensuring scientific consistency, compliance, and stakeholder engagement across multiple markets
- 05Lessons learned and best practices from global and regional implementation
In today’s rapidly evolving digital landscape, the banking sector faces increasingly sophisticated cyber threats. As banks continue to innovate and expand their digital services, ensuring robust cybersecurity measures is more critical than ever. This presentation, titled “Evolving Cybersecurity in the Banking Sector: Strategies for Adapting to Emerging Threats,” will explore the latest trends in cyber threats, discuss effective strategies for mitigating risks, and highlight best practices for maintaining security in an ever-changing environment. Join us as we delve into the challenges and solutions that are shaping the future of cybersecurity in banking.
CASE STUDY
Which KPIs Actually Prove Impact to Leadership?
Despite a decade long discussion, no true standards to measure the value and impact of Medical Affairs beyond measuring quantity (e.g. number of MSL interactions, number of publications) are established. Capturing clinical adoption and closing of care gaps as ultimate goals remains elusive for most companies. This presentation will focus on a framework with the pillars from activity metrics to changes in knowledge/beliefs/ behaviour to impact on patient outputs and outcomes including examples and interactive discussions.
Global collaboration between companies across the supply chain provides tremendous value to products brought to market, patient safety and understanding of evolving requirements. It allows for an increase in product quality, supports smooth registration processes and thus secures the time it takes to introduce the product to the market. A similar situation may also occur with cooperation with regulatory bodies; the exchange of knowledge and experience can only have a positive impact on product safety. As a person who has been supporting cooperation in the area of regulatory affairs for many years, I would like to show, based on examples, how many benefits it can bring.
- 01KPI framework
- 02Patient impact measurement
- 03Case discussions
- 04Implementation and pitfalls
CASE STUDY
Reimagining Global Medical Information: From Service to Strategic Impact
Global Medical Information is evolving from a reactive service to a strategic driver within Medical Affairs. This session explores how GMI can generate actionable insights, leverage digital and AI capabilities, and enable better decision-making across the organisation. We will highlight key enablers, organisational shifts, and practical approaches to unlock greater impact, positioning GMI as a critical contributor to scientific leadership and patient outcomes.
- 01From reactive answers to proactive insights
- 02Data, digital, and Al as key enablers
- 03Better, faster Medical Affairs decisions
- 04Integrated omnichannel engagement
- 05Impact over volume metrics
Traditionally, Regulatory Affairs relied on unstructured data that are maintained in documents. This is slowly but steadily changing as regulators demand the submission of structured data in addition to documents (e.g., XEVMPD and IDMP requirements). Being able to manage structured substance and product data will, in the future, be a prerequisite to further speed up the regulatory submission process and be a distinguishing factor in increasing development to market speed. Ontologies are a scalable approach to manage large quantities of regulatory data, break up data siloes and connect data even beyond regulatory requirements. We will dive into the world of ontologies to showcase how Regulatory Affairs can profit from this technological innovation.
CASE STUDY
Designing With, Not For: The Future of Patient Partnership in Medical Affairs
This session challenges Medical Affairs professionals to turn patient centricity from a guiding principle into a measurable practice — across how activities are designed, evidence is built, and outcomes are evaluated.
- 01Learn from experience: Explore what authentic co-creation with patients and advocacy groups truly requires — drawing on real-world examples
- 02Challenge the status quo: Examine where patient voice is genuinely shaping evidence and communications, and where critical gaps remain
- 03Build for impact: Begin establishing a practical framework to identify, address, and measure what real patient impact looks like in your organisation
Payit is UAE’s first fully featured digital wallet. This presentation narrates the story of how a digital wallet transformed financial transactions for families and communities in the region into joyful moments by thoughtfully curating experiences centred around customers’ spending, sending, and borrowing moments, enabled by the comfort and convenience of digital. This led to the wider acceptance of Payit and an upsurge in usage and profitable revenues.
CASE STUDY
How Can We Achieve True Patient Collaboration in Medical Affairs?
What do we mean by true patient collaboration? Why are medical affairs best placed to collaborate with patients? What are some of the challenges in true patient collaboration? What are the advantages of true patient collaboration? What could be some of the ways we can achieve this in the industry?
- 01Definition of patient engagement
- 02Why medical affairs
- 03Some challenges in true collaboration
- 04Some benefits of true patient collaboration
- 05What are we doing now and what can we do more of
This presentation will provide an in-depth analysis of the financial industry’s transformation, from its traditional banking roots to the rise of fintech and the disruptive influence of Web3 technologies. By examining the historical context, key innovations, and future implications, we will gain a comprehensive understanding of how the financial landscape has been reshaped and what the future holds for the industry. Join me to understand finance’s past, present, and future in a rapidly changing digital world.
CASE STUDY
Medical Affairs Strategy and Implementation – Adapt with Commercialisation Model
We will explore effective strategies for attracting and retaining top talent within the medical affairs sector. We will delve into the importance of creating a compelling employer brand and fostering a culture of continuous learning and development. Additionally, we will discuss the role of leadership in driving employee engagement, as well as insights and practical tools to enhance talent management practices and build a resilient, high-performing medical affairs team.
- 01Adapting Medical Affairs strategies to different commercialisation models
- 02Building and managing effective Medical Affairs capabilities within partner and distributor networks
- 03Supporting successful launches and lifecycle management (LCM) of specialty and rare disease products
- 04Ensuring scientific consistency, compliance, and stakeholder engagement across multiple markets
- 05Lessons learned and best practices from global and regional implementation
In today’s rapidly evolving digital landscape, the banking sector faces increasingly sophisticated cyber threats. As banks continue to innovate and expand their digital services, ensuring robust cybersecurity measures is more critical than ever. This presentation, titled “Evolving Cybersecurity in the Banking Sector: Strategies for Adapting to Emerging Threats,” will explore the latest trends in cyber threats, discuss effective strategies for mitigating risks, and highlight best practices for maintaining security in an ever-changing environment. Join us as we delve into the challenges and solutions that are shaping the future of cybersecurity in banking.
CASE STUDY
Which KPIs Actually Prove Impact to Leadership?
Despite a decade long discussion, no true standards to measure the value and impact of Medical Affairs beyond measuring quantity (e.g. number of MSL interactions, number of publications) are established. Capturing clinical adoption and closing of care gaps as ultimate goals remains elusive for most companies. This presentation will focus on a framework with the pillars from activity metrics to changes in knowledge/beliefs/ behaviour to impact on patient outputs and outcomes including examples and interactive discussions.
Global collaboration between companies across the supply chain provides tremendous value to products brought to market, patient safety and understanding of evolving requirements. It allows for an increase in product quality, supports smooth registration processes and thus secures the time it takes to introduce the product to the market. A similar situation may also occur with cooperation with regulatory bodies; the exchange of knowledge and experience can only have a positive impact on product safety. As a person who has been supporting cooperation in the area of regulatory affairs for many years, I would like to show, based on examples, how many benefits it can bring.
- 01KPI framework
- 02Patient impact measurement
- 03Case discussions
- 04Implementation and pitfalls
Ahmed Nasr
Operations Director Egypt and Director Milk Africa & Turkey
Khaled Elsharkawy
Integrated Supply Chain Senior Director
Mueen Uddin Siddique
Senior Director – Access Network Procurement
Shannon Hore
Senior Vice President Procurement and Logistics
Sandeep Sharma
Director Group Procurement & International Markets Supply Chain
Hottest topics
LOOK AT THE TOPICS THAT WILL BE DISCUSSED
- 01What does a truly future-fit Medical Affairs model look like and why do most fail?
- 02Measuring real impact on HCP behaviour and practice
- 03Registry design, data-source selection, and the methodological standards that satisfy both payers and regulators
- 04Do patient support programmes actually improve outcomes or just adherence metrics?
- 05How Medical Affairs teams are preparing to support novel endpoints that regulators are only beginning to understand
- 06Medical Affairs 2030: Are you preparing for AI disruption, empowered patients or reacting to it?
Testimonials
What our users say about our conferences
Sponsor
Our Trusted Sponsor at This Summit
STAY UPDATED FOR THE 2026 EDITION
With All the Updates Regarding the Upcoming Edition of This Event.